Drug intelligence / Profile preview

Tongbi Tuomin

Development stage: Preclinical
Lead developer: Jiangsu Provincial Hospital of Traditional Chinese Medicine
Modality: Drug Delivery Systems
Administration: Topical

Overview

Tongbi Tuomin is an ointment designed for external application, primarily investigated for the treatment of infantile allergic rhinitis. It is likely a Traditional Chinese Medicine (TCM) formulation, given the context of its development and the institutions involved in its clinical study. The specific active ingredients and detailed mechanism of action are not explicitly provided in the available information, beyond its intended use as a nasal desensitization ointment for external application in managing allergic rhinitis symptoms.

Beyond the preview

Go deeper on Tongbi Tuomin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongbi Tuomin.

Explore the full profile